Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday''s Mid-Day Session
Gainers NewAge, Inc. (NASDAQ: NBEV ) shares climbed 61.3% to $0.1972 on continued volatility after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code. The stock is rebounding after trading lower on Thursday. PaxMedica, Inc. (NASDAQ: PXMD ) surged 44.8% to $5.07. PaxMedica Executive Chairman, Director Michael Derby reportED in Form4 filing the purchase of 95,000 shares at $5.25 per share. Cheetah Mobile Inc.. (NYSE: CMCM ) shares jumped 36% to $4.5581 following effectiveness of its 1-for-5 reverse split. Bright Minds Biosciences Inc. (NASDAQ: DRUG ) gained 35% to $2.15. Bright Minds Biosciences recently initiated dosing in Phase I clinical trial of BMB-101 for Dravet Syndrome. Nano Labs Ltd (NASDAQ: NA ) shares climbed 34% to $6.02. Nano Labs reported the receipt of Nasdaq Hearings Panel''s decision to grant request for continued listing. Ampio Pharmaceuticals, Inc. (NYSE: AMPE ) gained 27% to $0.1180 after declining around 9% on Thursday. bioAffinity Technologies, Inc. (NASDAQ: BIAF ) rose 22.2% to $10.14 after jumping 36% on Thursday.
Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday''s Mid-Day Session
Gainers NewAge, Inc. (NASDAQ: NBEV ) shares climbed 61.3% to $0.1972 on continued volatility after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code. The stock is rebounding after trading lower on Thursday. PaxMedica, Inc. (NASDAQ: PXMD ) surged 44.8% to $5.07. PaxMedica Executive Chairman, Director Michael Derby reportED in Form4 filing the purchase of 95,000 shares at $5.25 per share. Cheetah Mobile Inc.. (NYSE: CMCM ) shares jumped 36% to $4.5581 following effectiveness of its 1-for-5 reverse split. Bright Minds Biosciences Inc. (NASDAQ: DRUG ) gained 35% to $2.15. Bright Minds Biosciences recently initiated dosing in Phase I clinical trial of BMB-101 for Dravet Syndrome. Nano Labs Ltd (NASDAQ: NA ) shares climbed 34% to $6.02. Nano Labs reported the receipt of Nasdaq Hearings Panel''s decision to grant request for continued listing. Ampio Pharmaceuticals, Inc. (NYSE: AMPE ) gained 27% to $0.1180 after declining around 9% on Thursday. bioAffinity Technologies, Inc. (NASDAQ: BIAF ) rose 22.2% to $10.14 after jumping 36% on Thursday.